DESIGN AND ACTIVITY STUDY OF XANTHINE DERIVATIVES AS DRUG CANDIDATE OF NON-SMALL CELL LUNG CANCER (NSCLC)
Lung cancer has the highest prevalence among all cancers, and the incidence and death cases continue to rise every year, reaching 2.2 million and 1.8 million in 2020, respectively. Approximately 85% of the cases are Non-Small Cell Lung Cancer (NSCLC), and the majority are diagnosed at an advanced st...
Saved in:
Main Author: | Amelia, Tasia |
---|---|
Format: | Dissertations |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/72694 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
HOMOLOGY MODELING AND IN SILICO STUDY OF LISTERIOLYSIN O AS NSCLC VACCINE CANDIDATE
by: Amelia, Tasia -
THE ONCOGENIC ROLE OF TREFOIL FACTOR 3 (TFF3) IN NON-SMALL CELL LUNG CANCER (NSCLC)
by: ZHANG MENGYI
Published: (2019) -
Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-small-cell Lung Cancer (NSCLC) : A Preliminary Study
by: Vorachai Ratanatharathorn, et al.
Published: (2018) -
Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)
by: Thanyanan Reungwetwattana, et al.
Published: (2018) -
Role of chaperone mediated autophagy (CMA) in the degradation of misfolded N-CoR protein in non-small cell lung cancer (NSCLC) cells
by: Ali, A.B., et al.
Published: (2014)